Stener Kvinnsland
Presidente presso Pluvia AS
Provenienza dei contatti di primo grado di Stener Kvinnsland
| Entità | Tipo di entità | Settore Industriale | |
|---|---|---|---|
| Public Company | Pharmaceuticals: Major | 33 | |
APIM Therapeutics AS
 APIM Therapeutics AS Pharmaceuticals: MajorHealth Technology APIM Therapeutics AS develops and commercializes novel anti-cancer therapies. It offers a physiological intervention point allowing the potentiation of the action of clinical drugs across multiple cancer indications. The company focuses on the development and commercialization of novel anti-cancer therapies potentiating chemo-therapy induced responses in cancer cells. The company was founded by Marit Otterlei in 2009 and is headquartered in Trondheim, Norway.
10
| Holding Company | Pharmaceuticals: Major | 10 |
Pluvia AS
 Pluvia AS Miscellaneous Commercial ServicesCommercial Services Pluvia AS operates as a research-based pharmaceutical company. The company is headquartered in Bergen, Norway.
6
| Holding Company | Miscellaneous Commercial Services | 6 |
Grafico delle società connesse in secondo grado
Relazione in diverse aziende
Società connesse a Stener Kvinnsland tramite i suoi contatti personali
| Società | Settore | Persone collegate | Posizione principale |
|---|---|---|---|
| University of Bergen | College/University | Doctorate Degree Corporate Officer/Principal Undergraduate Degree Doctorate Degree | |
| Norwegian School of Economics & Business Administration | College/University | Undergraduate Degree Masters Business Admin Graduate Degree | |
Investinor AS
 Investinor AS Investment ManagersFinance Investinor AS is a Venture Capital firm, a subsidiary of Innovasjon Norge founded in 2008. The company is headquartered in Trondheim. | Investment Managers | Chairman Private Equity Investor Private Equity Analyst | |
Sarsia Seed Management AS
 Sarsia Seed Management AS Investment ManagersFinance Sarsia Seed Management AS is a venture capital firm headquartered in Bergen, Norway. The company was founded in 2006. | Investment Managers | Chief Executive Officer Consultant / Advisor Private Equity Investor | |
| Norwegian University of Science & Technology | College/University | Corporate Officer/Principal Graduate Degree Graduate Degree | |
| University of Oxford | College/University | Doctorate Degree Graduate Degree Doctorate Degree | |
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Pharmaceuticals: Major | Director/Board Member Director/Board Member | |
| SPEXIS AG | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer Chief Executive Officer | |
Eli Lilly Norge AS
 Eli Lilly Norge AS Medical DistributorsDistribution Services Eli Lilly Norge AS engages in the provision of pharmaceutical products and services. Its commodities were developed for the treatment of diabetes, cardiovascular diseases, cancer, nervous system, osteoporosis, psoriasis, rheumatology, urology, and growth failure. The company was founded in 1976 and is headquartered in Oslo, Norway. | Medical Distributors | Corporate Officer/Principal Corporate Officer/Principal | |
| King's College London | College/University | Graduate Degree Graduate Degree | |
Papyrus Therapeutics, Inc.
 Papyrus Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Papyrus Therapeutics, Inc. is a preclinical stage biopharma American company that focuses on developing cancer therapeutics based on a novel target, opioid-binding cell adhesion molecule (OPCML). Papyrus Therapeutics is based in Oxford, UK. The company's expertise in this target is based on years of research and multiple publications by the company's co-founder and chief scientific adviser, Professor Hani Gabra. The company was founded by Paul Blake and Hani Gabra, and Paul Blake has been the CEO since incorporation. | Miscellaneous Commercial Services | Director/Board Member Founder | |
| ASTRAZENECA PLC | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Masters Business Admin Graduate Degree | |
The Norwegian Academy of Science & Letters
 The Norwegian Academy of Science & Letters Miscellaneous Commercial ServicesCommercial Services The Norwegian Academy of Science & Letters operates as a non-govern¬mental, nationwide, and interdisciplinary body which embraces all fields of learning. It engages in advancement of science and scholarship services. The company was founded in May 3, 1857 and is headquartered in Oslo, Norway. | Miscellaneous Commercial Services | Corporate Officer/Principal Corporate Officer/Principal | |
Ernst & Young AS
 Ernst & Young AS Miscellaneous Commercial ServicesCommercial Services Part of Ernst & Young Global Ltd., Ernst & Young AS is a Norwegian company that provides accounting services. The company is based in Oslo, Norway. The CEO of the company is Christin Erichsen Bøsterud. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
Piper Sandler Ltd.
 Piper Sandler Ltd. Investment Banks/BrokersFinance Part of Piper Sandler Cos., Piper Sandler Ltd. is a brokerage services provider. The company is based in London, UK. The British company was founded in 1999. Neil Robert Mackison has been the CEO of the company since 2006. | Investment Banks/Brokers | Chief Executive Officer Analyst-Equity | |
Caerus Capital AS
 Caerus Capital AS Pharmaceuticals: MajorHealth Technology Caerus Capital AS develops a process to produce heparin from marine raw materials. It focuses on developing novel anticoagulant agents based on biomass from the fish farming industry. The firm's technological platform is based on patented processes for extraction and purification of heparin using marine species-specifically salmon intestines-as raw material. The company was founded by Ragnar Flengsrud on December 4, 2001 and is headquartered in Hovik, Norway. | Pharmaceuticals: Major | Director/Board Member Chairman | |
Arxx Therapeutics AS
 Arxx Therapeutics AS BiotechnologyHealth Technology Arxx Therapeutics AS develops therapeutics for fibrotic diseases. The company is based in Oslo, Norway. The Norwegian company was founded in 2015 by Jonas Hallén, Jörg Klingelhöfer. Øystein Soug has been the CEO of the company since 2022. | Biotechnology | Director/Board Member Director/Board Member | |
Sarsia Innovation AS
 Sarsia Innovation AS Investment ManagersFinance Sarsia Innovation AS invests in companies located in the northern part of Norway. Selected companies are from various sectors but they all are developing new concepts in their field. The fund is currently closed for new investments. | Investment Managers | Director/Board Member Corporate Officer/Principal | |
| University of Cambridge | College/University | Undergraduate Degree Undergraduate Degree | |
Lifearc
 Lifearc Miscellaneous Commercial ServicesCommercial Services Lifearc provides research services. It specializes in intellectual property management, drug discovery, medical diagnostics and antibody engineering. The firm services include complete technology transfer service for scientists in MRC units and institutes, Awards to Inventors, Collaborative drug discovery and antibody engineering, Funding early stage research with commercial/translational potential and protecting new ideas. The company is headquartered in London, the United Kingdom. | Miscellaneous Commercial Services | Director/Board Member Chief Operating Officer | |
| University of Oslo | College/University | Graduate Degree Graduate Degree | |
| Oxford Brookes University | College/University | Masters Business Admin Graduate Degree | |
| THERACRYF PLC | Medical/Nursing Services | Chairman Director/Board Member | |
Symphogen A/S
 Symphogen A/S Pharmaceuticals: MajorHealth Technology Symphogen A/S provides antibody therapeutics for the treatment of cancers. It offers oncology products and creates selected antibody mixtures that address multiple oncology targets in a single drug product. The firm’s pipeline is fueled by its technology suite capable of identifying, selecting, manufacturing, and characterizing optimal antibody mixtures. The company was founded by Kirsten Aarup Drejer, Thomas Feldthus, Eigil Bjerl Nielsen, Anker Gunvald Lundemose, Kim Arthur Hueg, and John Soerensen Haurum in 2000 and is headquartered in Ballerup, Denmark. | Pharmaceuticals: Major | Corporate Officer/Principal Chief Executive Officer | |
Piramed Ltd.
 Piramed Ltd. Miscellaneous Commercial ServicesCommercial Services PIramed Ltd. develops drugs, diagnostics, and other therapeutic products. It develops treatment for cancers which include proliferation, invasion, angiogenesis, and metastasis. The company was co-founded by Michael Waterfield, Peter Parker, and Paul Workman in 2003 and is headquartered in Slough, UK. | Miscellaneous Commercial Services | Director/Board Member Corporate Officer/Principal | |
Cancer Research Technology Ltd.
 Cancer Research Technology Ltd. Medical SpecialtiesHealth Technology Cancer Research Technology Ltd. develops cancer therapeutics, vaccines, and diagnostics. The firm also provides project development, commercialization, drug discovery, clinical development, imaging, and funding services. The company was founded in 2002 and is headquartered in London, the United Kingdom. | Medical Specialties | Chief Executive Officer Corporate Officer/Principal | |
Uni Targeting Research AS
 Uni Targeting Research AS BiotechnologyHealth Technology Uni Targeting Research AS is a holding company that provides the biopharmaceutical industry with tools and services for mammalian cell-line based development procedures and production processes. It offers upstream solutions to reduce complementary deoxyribonucleic acid and mammalian cell-line based timelines and increase protein production yields. Its technology enables both enhanced synthesis/secretion of naturally secreted proteins, and secretion of intracellular proteins. Its services include vector improvement, tailor-made vectors, and tool proteins. The company was founded by Ian Fraser Pryme, John E. Hesketh, Albert Tauler, and Beate Stern in 2001 and is headquartered in Bergen, Norway. | Biotechnology | Director/Board Member Chairman | |
Biovista, Inc.
 Biovista, Inc. Internet Software/ServicesTechnology Services Biovista, Inc. operates as an artificial intelligence platform to develop pipeline drugs. The firm offers drug repositioning, personalized medicine, drug de risking, clinical hold and pipeline services. The company was founded by Aris Persidis and Andreas Persidis and is headquartered in Charlottesville, VA. | Internet Software/Services | Corporate Officer/Principal | |
| Apotech SA | Chief Tech/Sci/R&D Officer | ||
Sarsia Venture Management AS
 Sarsia Venture Management AS Investment ManagersFinance Sarsia Venture Management AS (SVM) is a venture capital advisory and management firm based in Bergen, Norway. They manage and advise the Sarsia Life Science Fund, established in 2005, which focuses on life science and biotechnology opportunities in the Nordic region. | Investment Managers | Private Equity Investor | |
| Medexis Biotech SA | Chief Executive Officer | ||
Gerolymatos International SA
 Gerolymatos International SA Pharmaceuticals: MajorHealth Technology Part of Alapis Holding Industrial & Commercial SA, Gerolymatos International SA is a Greek company that manufactures and distributes pharmaceutical products. The company is based in Kryoneri, Greece. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
DCC Healthcare Ltd.
 DCC Healthcare Ltd. Medical DistributorsDistribution Services DCC Healthcare Ltd. supplies medical, surgical, and laboratory equipment and pharmaceuticals to the Irish healthcare sector. The company is headquartered in Stillorgan, Ireland. | Medical Distributors | Chief Executive Officer | |
TeleVenture Capital AS
 TeleVenture Capital AS Investment ManagersFinance TeleVenture Capital AS is a venture capital investment firm based in Oslo. TeleVenture Capital traces their origins back to 1993 when the mobile telecommunications firm, Telenor Group, formed their venture capital arm, TeleVenture AS. In 1998, TeleVenture Capital AS was founded as a management firm to enable the establishment of additional venture capital funds. TeleVenture Capital focuses on investments in the information and communication technology sectors. TeleVenture Capital manages two venture capital funds, namely Telenor Venture II ASA and Telenor Venture IV AS. | Investment Managers | Private Equity Investor | |
| Norwegian Trade Council | Corporate Officer/Principal | ||
| VERNALIS | Pharmaceuticals: Major | Corporate Officer/Principal | |
SRI International
 SRI International Miscellaneous Commercial ServicesCommercial Services SRI International provides contract research and development services. It is an independent, nonprofit research institute conducting client-sponsored research and development for government agencies, commercial businesses, foundations, and other organizations. The company was founded in 1946 and is headquartered in Menlo Park, CA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| University of Kent | College/University | Undergraduate Degree | |
Odin Aero AS
 Odin Aero AS Miscellaneous Commercial ServicesCommercial Services Odin Aero AS develops services and operations of unmanned aerial vehicles. The firm also sells and produces drones. The company was founded on July 13, 2006 and is headquartered in Trondheim, Norway. | Miscellaneous Commercial Services | Chairman | |
CellCentric Ltd.
 CellCentric Ltd. Pharmaceuticals: MajorHealth Technology CellCentric Ltd. develops and commercializes small molecule inhibitors for cancer. Its active programs include inhibitors to histone methyltransferases, histone demethylases and epigenetic enzymes that act via ubiquitin. The company was founded by Alun Huw Jones, Catherine Denise Prescott, Azim Surani and William Henry Lewarne West in May 2004 and is headquartered in Cambridge, the United Kingdom. | Pharmaceuticals: Major | Chief Tech/Sci/R&D Officer | |
Hystorsys AS
 Hystorsys AS Industrial MachineryProducer Manufacturing Hystorsys AS provides hydrogen compressor and storage tanks. It develops, manufactures, and sells storage tanks and compression systems. The company was founded in 2005 and is headquartered in Kjeller, Norway. | Industrial Machinery | Director/Board Member | |
Bitreactive AS
 Bitreactive AS Packaged SoftwareTechnology Services Bitreactive AS develops software and java applications. It provides the Reactive Blocks Software Development Kit. With the reactive blocks, it builds applications graphically with reusable blocks, analyzes them with coverage, and generates reactive behavior automatically. The firm develops a marketplace for buying and selling of components for different applications in the Machine-to-Machine market and embedded systems. The company was founded by Frank Alexander Kraemer on June 28, 2011 and is headquartered in Trondheim, Norway. | Packaged Software | Chairman | |
| CRAYONANO | Semiconductors | Chairman | |
Holberg EEG AS
 Holberg EEG AS Packaged SoftwareTechnology Services Holberg EEG AS develops systematic computer based classification and reporting software. Its products for standardised structural interpretation, reporting and sharing of advanced diagnostic data and is currently focused in the field of electroencephalography. The company was founded by Harald Aurlien and Jan Brgger in 2009 and is headquartered in Bergen, Norway. | Packaged Software | Chairman | |
Glucoset AS
 Glucoset AS Electronic Equipment/InstrumentsElectronic Technology Glucoset AS engages in the development of glucose control technology. It offers glucose monitoring and sensors. The company is headquartered in Trondheim, Norway. | Electronic Equipment/Instruments | Director/Board Member |
Statistiche
Distribuzione geografica
| Norvegia | 26 |
| Regno Unito | 15 |
| Stati Uniti | 6 |
| Svizzera | 3 |
| Grecia | 3 |
Settori
| Health Technology | 15 |
| Consumer Services | 10 |
| Finance | 8 |
| Commercial Services | 8 |
| Technology Services | 4 |
Posizioni
| Director/Board Member | 154 |
| Corporate Officer/Principal | 87 |
| Chairman | 46 |
| Chief Tech/Sci/R&D Officer | 32 |
| Independent Dir/Board Member | 30 |
Contatti più connessi
| Insiders | |
|---|---|
| Susan Foden | 32 |
| François Thomas | 25 |
| Martin Olin | 25 |
| Hilde Furberg | 21 |
| Erlend Petter Skagseth | 17 |
| Jon-Øyvind Eriksen | 16 |
| Stein Holst Annexstad | 15 |
| Richard Stuart Godfrey | 15 |
| David Wilson | 14 |
| Jørgen André Nilsen | 13 |
| Anders Lennart Tullgren | 12 |
| Kari Grønås | 12 |
| Martin Welschof | 12 |
| Gayle Mills | 12 |
| Øivind Enger | 12 |
- Borsa valori
- Insiders
- Stener Kvinnsland
- Connessioni Società
